ASP-8374

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameASP-8374
Drug Alias NamePTZ-201ASP-8374
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionT cell immunoglobulin and ITIM domains inhibitors
TargetsT cell immunoglobulin and ITIM domains
Therapy Area/IndicationsSolid tumoursGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[9] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma IncPotenza Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncAstellas Pharma Global Development Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A